Skip to content
Home/Companies/Healthcare/RS²D

RS²D

Healthcare·France·Exited·Held 10yr
Entry
2016
Hold
10yr
Exit
–

Who owns RS²D?

RS²D is a French Healthcare company, formerly owned by Capital Grand Est (exit via Trade Sale). No current private equity owner is on file.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Capital Grand Est
Investor
Capital Grand Est
Alsace Croissance · 2011 · Growth

Key facts

HQFrance
SectorHealthcare
Exit Type
Trade Sale
Buyer
Nanalysis Scientific Corp.

More from Alsace Croissance

Other portfolio companies in the same fund.

EGH Industrie
Exited
IndustrialsFrance
Meazza Gide & De Angelis
Meazza Gide & De Angelis
Active
ConstructionFrance· 2026
Estudia
Exited
EducationFrance· 2022
Liconograf
Liconograf
Exited
EducationFrance· 2018
Proximis
Exited 2021
TMTFrance· 2017
to Planet
Fibermetrix
Fibermetrix
Active
TMTFrance· 2016

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns RS²D?

RS²D was formerly owned by Capital Grand Est. No current private equity owner is on file.

Who did RS²D sell to?

Capital Grand Est sold RS²D to Nanalysis Scientific (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue